| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8457722 | Nuclear Medicine and Biology | 2018 | 23 Pages |
Abstract
The presented work has the potential to allow physicians to identify papillary thyroid cancer patients at risk of metastases by using the novel immuno-PET imaging assay based on PDGFRα-targeting antibody [64Cu]Cu-NOTA-D13C6.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michael Wagner, Melinda Wuest, Ingrit Hamann, Ana Lopez-Campistrous, Todd P.W. McMullen, Frank Wuest,